MedPath

Prospective Longitudinal Cohort Study Children with Vision Impairment

Conditions
Low vision
10047518
Registration Number
NL-OMON55270
Lead Sponsor
Stichting ter Verbetering van het Lot der Blinden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

In order to obtain a representative research group, all children between the
selected ages who are registered at the regional centres of Bartiméus and Royal
Visio are invited to participate. Inclusion criteria are:
o For the baby cohort: Age at the start of participation in the project is
between six and 30 months. For the intensive cohort the age is between six and
20 months. For the teenager cohort: Initial age is between 12 and 14 years.
o The participant has to grow up in a family, with care by one or two
(foster/step)parents
o Parents and teenager partcipants master the Dutch language
o Registered at one of the regional centers of Bartiméus or Royal Visio. For
the teenager cohort, registration for special education or itinerant teacher
support also applies.
o The following information must be present: visual functioning (minimum vision
both eyes together or best eye, field of vision), type of eye condition,
disorder/disease/syndrome, date of birth, term date, status comorbid disorders
and sex.

Parents and siblings of the children with VI (if present) will be involved in
the study and they are asked to participate in the measurements. Participation
of (a) parent(s) is compulsory, that of siblings is not. There is no age limit
for the siblings when participating in video recordings (intensive cohort). For
the measurements among well-being (extensive cohort), siblings should be at
least four years old.

Exclusion Criteria

Children with clear multiple disabilities are excluded. This applies to the
starting moment of participation in the project. For the baby cohort, children
who may turn out to have multiple disabilities at a later age can participate
in the project.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath